Health

Results: 5305-5316 of 6099

PR Newswire associated0

Amorphical brings Scientific Breakthrough - Treating and Curing Chronic Inflammatory and Oncological Diseases

National call for volunteers to test ground-breaking psychedelic treatments for mental health conditions

Today Essity holds the webcast - Innovating for profitable and sustainable growth

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024

Walmart Foundation commits $1 million to support humanitarian aid in Gaza

PR Newswire associated0

Fitness Superstore announce partnership with professional athlete Zack George

Transat Jacques Vabre: Alberto Bona and Pablo Santurde del Arco on the Class40 IBSA after crossing the finish line in Fort-de-France, Martinique (©IBSA | Beppe Raso)

Alberto Bona on Board the Class40 IBSA Finishes the Transat Jacques Vabre in Third Place

STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage. (Graphic: Business Wire)

STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

AI-enabled Home Healthcare Provider Cera Care to Save the UK Government & Hospitals £100M This Winter by Committing to 5 Million Care Visits

Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations

DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia

Calliditas' partner Everest Medicines announces China NMPA's approval of Nefecon® for the treatment of primary IgA nephropathy